80% increase in dose intensity of cyclophosphamide, epirubicin and fluorouracil does not improve metastatic breast cancer response rate

Alberto Riccardi, Marco Danova

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)193-196
Number of pages4
JournalEvidence-based Oncology
Volume2
Issue number4
DOIs
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Oncology

Cite this